DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 213 filers reported holding DEPOMED INC in Q3 2015. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $164,000 | -28.4% | 24,598 | -29.2% | 0.01% | -38.5% |
| Q1 2018 | $229,000 | -46.7% | 34,734 | -35.0% | 0.01% | -43.5% |
| Q4 2017 | $430,000 | +75.5% | 53,448 | +26.5% | 0.02% | +64.3% |
| Q3 2017 | $245,000 | -69.3% | 42,250 | -33.6% | 0.01% | -75.4% |
| Q1 2017 | $799,000 | +137.1% | 63,676 | +240.8% | 0.06% | +111.1% |
| Q4 2016 | $337,000 | -42.6% | 18,683 | -55.6% | 0.03% | -20.6% |
| Q1 2016 | $587,000 | -59.8% | 42,114 | -47.7% | 0.03% | -60.5% |
| Q4 2015 | $1,461,000 | -35.1% | 80,574 | -32.5% | 0.09% | -24.6% |
| Q3 2015 | $2,251,000 | +215.7% | 119,415 | +259.4% | 0.11% | +225.7% |
| Q2 2015 | $713,000 | +45.2% | 33,228 | +51.6% | 0.04% | +45.8% |
| Q1 2015 | $491,000 | +234.0% | 21,925 | +140.1% | 0.02% | +200.0% |
| Q4 2014 | $147,000 | +241.9% | 9,131 | +226.1% | 0.01% | +166.7% |
| Q3 2014 | $43,000 | -89.8% | 2,800 | -90.7% | 0.00% | -88.0% |
| Q2 2014 | $421,000 | – | 30,252 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DELTEC ASSET MANAGEMENT LLC | 2,159,164 | $32,798,000 | 7.35% |
| Senvest Management, LLC | 4,515,935 | $68,597,000 | 6.42% |
| Broadfin Capital, LLC | 2,313,702 | $35,145,000 | 3.68% |
| HAYS ADVISORY LLC | 512,820 | $7,790,000 | 1.03% |
| Ghost Tree Capital, LLC | 120,000 | $1,823,000 | 0.99% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 647,096 | $9,829,000 | 0.94% |
| TURNER INVESTMENTS LLC | 817,177 | $12,413,000 | 0.74% |
| EMERALD ADVISERS, LLC | 681,346 | $10,350,000 | 0.62% |
| TSP Capital Management Group, LLC | 86,300 | $1,311,000 | 0.60% |
| PERKINS CAPITAL MANAGEMENT INC | 38,500 | $585,000 | 0.49% |